This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top Analyst Reports for Novo Nordisk, Honeywell & American Tower
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Honeywell International Inc. (HON) and American Tower Corporation (AMT).
Markel Group Q1 Earnings Top Estimates on Solid Reinsurance Unit
by Zacks Equity Research
MKL's Q1 results reflect solid performance at the Reinsurance segment, improved net investment income and lower expenses, offset by decreased premiums.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge.
Honeywell's Q1 Earnings & Revenues Beat Estimates, Increase Y/Y
by Zacks Equity Research
HON's first-quarter results benefit from growth in commercial aftermarket, defense & space and warehouse and workflow solutions. Softness across the safety & sensing technologies businesses hurts results.
Trade Balance in Goods Hits All-Time Record, Plus Q1 Earnings
by Mark Vickery
Pre-market futures are mixed-to-flat once again, this time with the blue-chip Dow leading into positive territory.
Here's What Key Metrics Tell Us About Honeywell International (HON) Q1 Earnings
by Zacks Equity Research
Although the revenue and EPS for Honeywell International (HON) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Honeywell International Inc. (HON) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Honeywell International (HON) delivered earnings and revenue surprises of 13.57% and 2.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
3M Gains 8.9% Post Q1 Earnings: Here's How to Play the Stock
by Avisekh Bhattacharjee
With MMM's shares gaining 8.9% after reporting first-quarter results, let us find the best strategy for investors now.
Zacks Industry Outlook Highlights Honeywell, 3M, Carlisle and Griffon
by Zacks Equity Research
Honeywell, 3M, Carlisle and Griffon have been highlighted in this Industry Outlook article.
Honeywell Gears Up to Report Q1 Earnings: What to Expect?
by Zacks Equity Research
HON's first-quarter results are likely to benefit from strong demand in the air transport and business aviation markets.
4 Diversified Operations Stocks to Consider on Promising Industry Trends
by Susmita Roy
The Zacks Diversified Operations industry has been gaining from strength across the aerospace, defense, and oil & gas markets. HON, MMM, CSL and GFF are some notable stocks in the industry.
ITT (ITT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
ITT (ITT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unveiling Honeywell International (HON) Q1 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Honeywell International (HON), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Honeywell International Inc. (HON) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the most recent trading session, Honeywell International Inc. (HON) closed at $197.31, indicating a -0.53% shift from the previous trading day.
TMUS Set to Report Q1 Results: Will Revenue Growth Boost Earnings?
by Zacks Equity Research
T-Mobile's Q1 top line is likely to have benefited from healthy demand for postpaid services.
Honeywell International Inc. (HON) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Honeywell International (HON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Honeywell International Inc. (HON) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Honeywell International Inc. (HON) closed at $196.60 in the latest trading session, marking a +1.72% move from the prior day.
Should You Buy, Sell or Hold 3M Stock Before Q1 Earnings?
by Avisekh Bhattacharjee
As MMM gears up to report first-quarter earnings, let us find out how the expectations stack up and whether it is the right time to buy, hold or sell the stock.
Bull of the Day: Griffon (GFF)
by Shaun Pruitt
Griffon Corporation's (GFF) stock can provide the diversification that investors may need during an ongoing trade war.
IAC (IAC) Moves 8.8% Higher: Will This Strength Last?
by Zacks Equity Research
IAC (IAC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Honeywell International (HON) Surges 8.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Honeywell International (HON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Will Honeywell International (HON) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Honeywell International (HON) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Garmin's Ongoing Product Innovation a Sign to Buy the Stock?
by Zacks Equity Research
GRMN is well-positioned for sustained growth due to its continuous product innovation, which investors can see as a compelling entry point in 2025.
Honeywell International Inc. (HON) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the most recent trading session, Honeywell International Inc. (HON) closed at $215.99, indicating a +1.19% shift from the previous trading day.
Honeywell Stock Trading at a Premium Value: Should You Buy, Sell or Hold?
by Avisekh Bhattacharjee
With HON's premium valuation, lowered earnings estimate revisions and near-term challenges, should investors reconsider their position in the stock?